Last reviewed · How we verify
Compound 21
At a glance
| Generic name | Compound 21 |
|---|---|
| Sponsor | Anna Stanhewicz, PhD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Compound 21 CI brief — competitive landscape report
- Compound 21 updates RSS · CI watch RSS
- Anna Stanhewicz, PhD portfolio CI